Electronic Cigarettes Granted Two-Year Grace Period Under Proposed FDA Rule
This article was originally published in The Tan Sheet
FDA proposed rule allows e-cigarettes and other products newly deemed as FDA-regulated to remain available for sale without approval by the agency until two years after the proposal becomes a final rule. Before the end of the two years firms must submit pre-market approval applications for each product.
You may also be interested in...
The U.K. pharma regulator requires all electronic cigarettes to be licensed as nonprescription medicines beginning in 2016, noting concerns about product quality. Meanwhile, FDA considers allowing e-cigarettes to be marketed as nicotine replacement therapy on a case-by-case basis.
So full of errors were the firm's online ads for its Plavinol supplement, the National Advertising Division noted support for some claims contained "many of the same flaws" as others. The prevalence of problems prompted NAD to go outside its "scope of review" and note unclear instructions on Plavinol labels.